The emergence of WT1-specific T-cell responses following allogeneic T cell-depleted hematopoietic stem cell transplantation and low-dose donor lymphocyte infusions is associated with a graft-vs.- myeloma effect

TY - JOUR

T1 - The emergence of WT1-specific T-cell responses following allogeneic T cell-depleted hematopoietic stem cell transplantation and low-dose donor lymphocyte infusions is associated with a graft-vs.- myeloma effect

AU - Tyler, Eleanor M

AU - Koehne, Guenther

N1 - Allogeneic stem cell transplantation (alloSCT) remains a potentially curative option for multiple myeloma (MM) patients. Lower relapse rates have been reported for alloSCT as compared with autologous SCT, most likely due to the graft-vs.-myeloma (GvM) effect elicited by donor lymphocytes.

PY - 2013/1/7

Y1 - 2013/1/7

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782135/

U2 - 10.4161/onci.24963

DO - 10.4161/onci.24963

M3 - Article

VL - 2

JO - OncoImmunology

JF - OncoImmunology

ER -